| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Institut Cochin de Génétique Moléculaire Centre Nationale de la Recherche Scientifique UPR 0415 75014 Paris, France
The present study demonstrates negative
intracellular cross-talk between angiotensin II type 2
(AT2) and insulin receptors.
AT2 receptor stimulation leads to inhibition of
insulin-induced extracellular signal-regulated protein kinase (ERK2)
activity and cell proliferation in transfected Chinese hamster ovary
(CHO-hAT2) cells. We show that AT2 receptor
interferes at the initial step of insulin signaling cascade, by
impairing tyrosine phosphorylation of the insulin receptor (IR)
ß-chain. AT2-mediated inhibition of IR
phosphorylation is insensitive to pertussis toxin and is also detected
in neuroblastoma N1E-115 and pancreatic acinar AR42J cells that express
endogenous receptors. We present evidence that
AT2 receptor inhibits the
autophosphorylating tyrosine kinase activity of IR, with no
significant effect on insulin binding properties.
AT2-mediated inactivation of IR does not mainly
involve tyrosine dephosphorylation by vanadate-sensitive
tyrosine phosphatases nor serine/threonine phosphorylation by protein
kinase C. As a consequence of IR inactivation,
AT2 receptor inhibits tyrosine phosphorylation
of insulin receptor substrate-1 (IRS-1) and signal-regulatory protein
(SIRP
1) and prevents subsequent association of both IRS-1 and
SIRP
1 with Src homology 2 (SH2)-containing tyrosine phosphatase
SHP-2. Our results thus demonstrate functional trans-inactivation of IR
kinase by G protein-coupled AT2 receptor,
illustrating a novel mode of negative communication between two
families of membrane receptors.
This article has been cited by other articles:
![]() |
B. Plouffe, M.-O. Guimond, H. Beaudry, and N. Gallo-Payet Role of Tyrosine Kinase Receptors in Angiotensin II AT2 Receptor Signaling: Involvement in Neurite Outgrowth and in p42/p44mapk Activation in NG108-15 Cells Endocrinology, October 1, 2006; 147(10): 4646 - 4654. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-M. Samuelsson, E. Bollano, R. Mobini, B.-M. Larsson, E. Omerovic, M. Fu, F. Waagstein, and A. Holmang Hyperinsulinemia: effect on cardiac mass/function, angiotensin II receptor expression, and insulin signaling pathways Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H787 - H796. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. C. Calegari, M. Alves, P. K. Picardi, R. Y. Inoue, K. G. Franchini, M. J. A. Saad, and L. A. Velloso Suppressor of Cytokine Signaling-3 Provides a Novel Interface in the Cross-Talk between Angiotensin II and Insulin Signaling Systems Endocrinology, February 1, 2005; 146(2): 579 - 588. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nouet, N. Amzallag, J.-M. Li, S. Louis, I. Seitz, T.-X. Cui, A.-M. Alleaume, M. Di Benedetto, C. Boden, M. Masson, et al. Trans-inactivation of Receptor Tyrosine Kinases by Novel Angiotensin II AT2 Receptor-interacting Protein, ATIP J. Biol. Chem., July 9, 2004; 279(28): 28989 - 28997. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Gendron, J.-F. Oligny, M. D. Payet, and N. Gallo-Payet Cyclic AMP-independent Involvement of Rap1/B-Raf in the Angiotensin II AT2 Receptor Signaling Pathway in NG108-15 Cells J. Biol. Chem., January 31, 2003; 278(6): 3606 - 3614. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-X. Cui, H. Nakagami, C. Nahmias, T. Shiuchi, Y. Takeda-Matsubara, J.-M. Li, L. Wu, M. Iwai, and M. Horiuchi Angiotensin II Subtype 2 Receptor Activation Inhibits Insulin-Induced Phosphoinositide 3-Kinase and Akt and Induces Apoptosis in PC12W Cells Mol. Endocrinol., September 1, 2002; 16(9): 2113 - 2123. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shibasaki, H. Matsubara, Y. Nozawa, Y. Mori, H. Masaki, A. Kosaki, Y. Tsutsumi, Y. Uchiyama, S. Fujiyama, A. Nose, et al. Angiotensin II Type 2 Receptor Inhibits Epidermal Growth Factor Receptor Transactivation by Increasing Association of SHP-1 Tyrosine Phosphatase Hypertension, September 1, 2001; 38(3): 367 - 372. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-X. Cui, H. Nakagami, M. Iwai, Y. Takeda, T. Shiuchi, L. Daviet, C. Nahmias, and M. Horiuchi Pivotal role of tyrosine phosphatase SHP-1 in AT2 receptor-mediated apoptosis in rat fetal vascular smooth muscle cell Cardiovasc Res, March 1, 2001; 49(4): 863 - 871. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |